pharma · Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) · IgA Nephropathy (IgAN) · VERA
Vera Therapeutics
VERALOX Therapeutics is a pharma organization headquartered in Frederick, USA. It trades on NYSE under ticker VERA. Primary therapeutic focus areas include Recurrent Low-Grade Serous Ovarian Cancer (LGSOC), IgA Nephropat
Company details
- Status
- Public
- HQ
- 4539 Metropolitan Ct, Frederick, Maryland 21704, US
- Founded
- 2018
- Employees
- 9
- Programs
- 25
- Drugs
- 32
- Patents
- 140
Quick answer
VERALOX Therapeutics is a pharma organization headquartered in Frederick, USA. It trades on NYSE under ticker VERA. Primary therapeutic focus areas include Recurrent Low-Grade Serous Ovarian Cancer (LGSOC), IgA Nephropathy (IgAN), HER2 Enriched Subtype Breast Cancer, Herzuma, PAM50 Study, Coronary Artery Disease, Hepatitis B, Chronic. NovaPharmaNews links 25 clinical program(s), 2 drug profile(s), and 140 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 2 (13), phase 3 (4), approved (4).
Company snapshot
Accelerating development of first-in-class therapeutics for unmet medical needs
- 2 approved product(s) across US/EU regulatory metadata.
- 25 active pipeline program(s) linked via ClinicalTrials.gov.
- 140 US patent(s) indexed to this assignee profile.
Public regulatory, clinical, patent, and corporate records for Vera Therapeutics. Not investment advice.
Catalysts
Upcoming readouts, regulatory dates, and congress activity.
- trial_data
New Radiopharmaceutical Shows Promise in Post-Pluvicto Setting, Offering Competitive Insights
Recent coverage
Top assets
Lead pipeline drugs
- Marketed / approved
- approved
- approved
- approved
Active clinical programs
- Phase 3
- Phase 3
- Phase 3
- Phase 3
Momentum
Proprietary activity score for Vera Therapeutics.
2 active signals
Signal breakdown
- Clinical trials
- Nova articles
- Patents filed
- FDA actions
- SEC filings
- Conference presentations
- Pipeline advances
Competitor landscape
Therapeutic-area overlap peers from registry and pipeline signals.
- Peer + 0 momentum
- Peer + 0 momentum
Recent activity
Latest pipeline, patent, and corporate events for Vera Therapeutics.
- Clinical update
- Clinical update
- Clinical update
- Clinical update
- Clinical update
Quick answers
Common questions about this sponsor — for analysts and search.
-
What is Vera Therapeutics?
-
Is Vera Therapeutics publicly traded?
-
What drugs does Vera Therapeutics develop or market?
-
What are the latest developments for Vera Therapeutics?
-
What therapeutic areas does Vera Therapeutics focus on?
Therapeutic focus
Therapeutic area distribution
Pipeline concentration by therapeutic area from linked clinical programs.